R. Milroy (Glasgow, United Kingdom), E. Jakobsen (Odense, Denmark), D. Jovanovic (Beograd, Republic of Serbia)
The National Lung Cancer Audit – Year 5 completeness and outcomes and case-mix adjustment
P. Beckett, R. Stanley, I. Woolhouse, L. Tata, M. Peake (London, Leeds, Nottingham, United Kingdom)
|   |
Improvement of the survival of lung cancer in a French monocentric cohort between 1990 and 2010
F. Vaylet, J. Margery, H. Le Floch, F. Riviere, A. Mairivitz, I. N‘Gampolo, W. Gaspard, J. P. Arigon, F. Pons, R. Jancovici, C. Marotel, P. L‘Her (Clamart, France)
| |
Survival outcomes of non small cell lung cancer (NSCLC) patients who are suitable for radical treatment at initial presentation
M. A. Khalil, J. Barclay (Oldham, Greater Manchester, United Kingdom)
| |
Survival outcomes in advance non-small cell lung cancer – A developing country scenario
R. Guleria, A. Mohan, S. Kumar, A. Ali, A. Kumar (Delhi, India)
| |
The role of chemotherapy re-challenge in non small cell lung cancer. A retrospective study in a tertiary general hospital and thoracic center
A. S. Strimpakos, E. Patsourou, D. Pouli, C. Fevranoglou, I. Giozos, A. Charpidou, K. N. Syrigos (Athens, Greece)
| |
Curative treatment vs. best supportive care in advanced non small cell lung cancer in aged person
J. Lee, J. Chang, J. Kim, Y. Ryu, S. Kim (Seoul, Republic Of Korea)
| |
Assessment of German national lung cancer guideline quality indicators in routine practice – Does the new TNM-system make a difference?
T. Blum, J. Kollmeier, N. Schönfeld, W. Ammenwerth, S. Delis, W. Grüning, W. Nehls, T. T. Bauer (Berlin, Germany)
| |
Outcome of patients discharged from rapid access lung clinic (RALC) with non cancer diagnosis: Five year follow up
A. Wight, R. Sarkar, L. Creech, R. Stead, M. Babores (Macclesfield, United Kingdom)
| |
Reducing unscheduled attendances at hospital due to lung cancer via a rapid access flexible clinic
H. Morgan, L. Hodgson, R. Lee, S. Doffman (Brighton, United Kingdom)
| |
Rapid access lung cancer clinic – A patient satisfaction survey
R. Mustafa, S. Naik, J. Mills, M. Munavvar (Preston, United Kingdom)
| |
How do patient and hospital features influence outcomes in small cell lung cancer in England?
A. Rich, L. Tata, C. Free, R. Stanley, M. Peake, D. Baldwin, R. Hubbard (Nottingham, Leicester, Leeds, United Kingdom)
| |
A retrospective analysis of patient presentation to primary and secondary care prior to subsequent late stage lung cancer diagnosis
A. Shah, S. Teoh, B. Mann (London, United Kingdom)
| |
General practitioner (GP) communication with potential lung cancer patients; review of practices prior to onward secondary care referral
S. Selvaraj, K. Garbett, J. McAdam, K. Srinivasan, H. Moudgil (Telford, Keele, United Kingdom)
| |
Does raising awareness of lung cancer symptoms in primary care alter referral patterns?
R. Astin, E. Paddison, A. Woolf, N. Soobadoo, D. Powrie (Southend, United Kingdom)
| |
Outcome of lung cancer alerts in chest X-rays
R. Sarkar, M. Jafary, J. Samanuru, N. O‘Reilly, A. de Ramón Casado (Warrington, United Kingdom)
| |
A repeat audit of computed tomography scanning prior to fibreoptic bronchoscopy in the diagnosis of lung cancer
J. Seymour, T. Ho (Frimley, United Kingdom)
| |
Validation of existing clinical prediction models for patients with solitary pulmonary nodules (SPN) managed by a lung multi-disciplinary team (MDT)
P. Malhotra, N. Lovell, P. Plant, S. Karthik, A. Scarsbrook, M. Callister (Leeds, United Kingdom)
| |
The value of immunohistochemical markers in the differential diagnosis of adenocarcinomas
A. Eylen, A. Karalezli, O. Kandemir, G. Aykun, H. Hasanoglu (Ankara, Turkey)
| |
NeuroStation – Statistical software based on artificial intelligence and pattern recognition for NSCLC development prediction through comprehensive biomarker analysis
N. Minic, S. Zunic, S. Zunic (Belgrade, Republic Of Serbia)
| |